Executive Team
HyperBranch's executive team members each average more than 20 years of experience in running commercially successful organizations and understand the business needs and commercial realities of the markets that the Company is focusing on.
- John Conn, MBA
President & Chief Executive Officer - Mark W. Grinstaff, Ph.D.
Co-founder - Jeff Clark, M.S.
Chief Operations Officer
Board of Directors
- John Conn, MBA
- Robert V. Toni
About Us
HyperBranch Medical Technology is a biosurgical device company focused on the design, development, and manufacture of novel surgical sealants for general and specialty surgery use, including general surgery, ocular surgery, and plastic cosmetic & reconstructive surgery.
Founded in March 2003 and based in Durham, North Carolina, HyperBranch is a privately-held biosurgical device company, formed to develop biosurgical devices based on its proprietary polymers and their cross-linked hydrogels. Its initial focus is on the surgical sealant market to help reduce the morbidity and mortality of patients undergoing surgery.
The Company's polymer technology evolved from the early work of its scientific co-founder, Dr. Grinstaff. HyperBranch scientists and engineers have invented a family of unique polymers and their crosslinked hydrogels. HyperBranch is now developing these proprietary hydrogels into surgical sealants. HyperBranch's tunable hydrogels confer material properties of biocompatibility with superior tissue adherence, strength, and durability. Additionally, HyperBranch's hydrogels are uniquely hemostatic, easy to use, and have a low manufacturing cost.